COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

Putman, Michael; Kennedy, Kevin; Sirotich, Emily; Liew, Jean W; Sattui, Sebastian E.; Moni, Tarin T; Akpabio, Akpabio A; Alpizar-Rodriguez, D.; Angevare, Saskya; Beesley, Richard; Bérenbaum, Francis; Buliņa, Inita; Chock, Yu Pei Eugenia; Conway, Richard; Duarte‐García, Alí; Singh, Abhishek; Duff, Eimear; Durrant, Karen L; Gheita, Tamer A.; Hill, Catherine; Howard, Richard A; Hoyer, Bimba F.; Hsieh, Evelyn; Kibbi, Lina El; Kilian, Adam; Kim, Alfred H.J.; Liew, David; Lo, Chieh; Mateus, Elsa F; Miller, Bruce; Mingolla, S.; Nudel, Michal; Singh, Jasvinder A; Singh, Namrata; Ugarte‐Gil, Manuel F.; Wallace, John F.; Young, Kristen J.; Tehozol, Erick Adrian Zamora; Bhana, Suleman; Costello, Wendy; Grainger, Rebecca; Machado, Pedro; Robinson, Philip C; Sufka, Paul; Wallace, Zachary S; Yazdany, Jinoos; Harrison, Carly; Larché, Maggie; Levine, Mitchell; Foster, Gary; Thabane, Lehana; Hausmann, Jonathan S; Sparks, Jeffrey A.; Simard, Julia F.

doi:10.1016/s2665-9913(22)00001-7

Cited by 33 publications

(39 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Almost all of those unsure or unwilling cited worries regarding side effects, safety, and the fast development and deployment of COVID‐19 vaccinations in clinical practice. Despite this, over half of the respondents reported they were pro‐vaccine, while many others expressed varying degrees of apprehension: 98.5% of the unsure respondents and 66.9% of unwilling respondents mentioned that they would be more inclined to get vaccinated if a rheumatologist recommended it, and additional outcomes data are available 36 . Compared with the general population, systemic IRD patients vaccinated for COVID‐19 showed comparable adverse events 37 .…”

Section: Discussionmentioning

confidence: 99%

COVID‐19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID‐19 Global Rheumatology Alliance (C19‐GRA) physician registry

et al. 2022

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

COVID‐19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID‐19 Global Rheumatology Alliance (C19‐GRA) physician registry

et al. 2022

View full text Add to dashboard Cite

show abstract

“…COVID-19 VH was maximum among those with existing comorbidities, probably driven by reports similar to those by Kaur et al, which cautioned against administering COVID-19 vaccines in females and those with co-morbidities. Additionally, a large multi-centered survey among rheumatology patients from 102 countries ( n = 7005) suggested that VH was mainly associated with a fear of side effects [ 17 ]. Recent articles claimed that COVID-19 vaccines protect individuals from severe infections for up to a period of 9 months, and the immunity may wane within a few months [ 18 , 19 ].…”

Section: Discussionmentioning

confidence: 99%

COVID-19 Vaccine Hesitancy: The Perils of Peddling Science by Social Media and the Lay Press

et al. 2022

View full text Add to dashboard Cite

Introduction: Vaccines are the best tools to end the pandemic, and their public acceptance is crucial in achieving herd immunity. Despite global efforts to increase access to vaccination, the World Health Organization explicitly lists vaccination hesitancy (VH) as a significant threat. Despite robust safety reports from regulatory authorities and public health advisories, a substantial proportion of the community remains obsessed with the hazards of vaccination. This calls for identifying and eliminating possible causative elements, among which this study investigates the inappropriate dissemination of medical literature concerning COVID-19 and adverse events following immunization (AEFI), its influence on promoting VH, and proposals for overcoming this problem in the future. Methods: We searched PubMed, Embase, and Scopus databases, using the keywords “adverse events following immunization (AEFI),” “COVID-19”, “vaccines,” and “hesitancy”, and related medical and subjective headings (MeSH) up to 31st March 2022, and extracted studies relevant to the COVID-19 AEFI and associated VH. Finally, 47 articles were chosen to generate a narrative synthesis. Results: The databases depicted a steep rise in publications on COVID-19 AEFI and COVID-19 VH from January 2021 onwards. The articles depicted multiple events of mild AEFIs without fatal events in recipients. While documenting AEFIs is praiseworthy, publishing such reports without prior expert surveillance can exaggerate public apprehension and inappropriately fuel VH. VH is a deep-rooted phenomenon, but it is difficult to zero in on the exact reason for it. Spreading rumors/misinformation on COVID-19 vaccines might be an important provocation for VH, which includes indiscriminately reporting AEFI on a massive scale. While a number of reported AEFIs fall within the acceptable limits in the course of extensive COVID-19 vaccinations, it is important to critically evaluate and moderate the reporting and dissemination of AEFI in order to allay panic. Conclusions: Vaccination programs are necessary to end any pandemic, and VH may be attributed to multiple reasons. VH may be assuaged by initiating educational programs on the importance of vaccination, raising public awareness and monitoring the inappropriate dissemination of misleading information. Government-initiated strategies can potentially restrict random AEFI reports from lay epidemiologists and healthcare practitioners.

show abstract

“…In fact, hesitance to receive the COVID-19 vaccinations have been reported with waning uptake of vaccination observed in the UK and other countries [ 26 ]. In addition, a global study demonstrates the hesitancy of individuals with autoimmune and rheumatic diseases [ 27 ].…”

Section: Discussionmentioning

confidence: 99%

Shielding reduced incidence of COVID-19 in patients with inflammatory arthritis but vulnerability is associated with increased mortality

et al. 2022

View full text Add to dashboard Cite

Objectives Investigate whether individuals with inflammatory arthritis, their treatments and shielding status affect the risk of adverse outcomes from COVID-19 for the entire population of Wales, U.K. Methods Retrospective, population-based cohort study using linked, anonymised electronic health data from SAIL Databank, including primary/secondary care, rheumatology, Office for National Statistics Mortality and COVID-19 laboratory data. Individuals aged 18 years and over testing positive for COVID-19 between March 2020 and May 2021 with READ Codes present for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis formed the study cases. Results A total of 1,966 people with IA and 166 602 without tested positive for COVID-19. The incidence rate was 3.5% (1,966/56 914) in IA, vs 6% in the general population (166 602/2,760 442), (difference: 2.5%, 95% CI: 2.4% to 2.7%, p = <0.001). In an adjusted Cox proportional hazard model, IA was not associated with higher mortality (HR: 0.56, 95% CI: 0.18–1.64, p= 0.286). Significant risk factors included shielding (HR: 1.52, 95% CI: 1.40–1.64, p = <0.001), hospitalisation for previous infections (HR: 1.20, 95% CI: 1.12–1.28, p = <0.001), hospitalisations one year pre-pandemic (HR: 1.34, 95% CI: 1.25–1.44, p = <0.001) and glucocorticoid use (HR: 1.17, 95% CI: 1.09–1.25, p = <0.001). Conclusions Individuals with IA had a lower incidence of COVID-19, probably due to shielding. IA was not associated with increased mortality following COVID-19 infection; being vulnerable (shielded), comorbidities and other factors were associated with increased risk. These key risk factors can identify individuals with IA at greater risk from COVID-19 and advised to shield during high community prevalence.

show abstract

COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

Cited by 33 publications

References 9 publications

COVID‐19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID‐19 Global Rheumatology Alliance (C19‐GRA) physician registry

COVID‐19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID‐19 Global Rheumatology Alliance (C19‐GRA) physician registry

COVID-19 Vaccine Hesitancy: The Perils of Peddling Science by Social Media and the Lay Press

Shielding reduced incidence of COVID-19 in patients with inflammatory arthritis but vulnerability is associated with increased mortality

Contact Info

Product

Resources

About